Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
RCEL · against 1,335 other Healthcare companies
Ranked #1,183 of 1,336 · scores higher than 11% of peers
Bars: peers in each 10-point band of the profitability score134 peers with a profitability score of 10–19, including RCEL · Click a bar to see the companies
Mainly because of its return on invested capital, return on assets and operating margin, which are weaker than most Healthcare peers.
| Metric | RCEL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 1,226 reported | -198.4% | 4.7% | 4% | 33% | |
| Operating marginHigher is better · 1,251 reported | -59.4% | 7.1% | 15% | 33% | |
| Return on assetsHigher is better · 1,315 reported | -41.6% | 1.7% | 9% | 33% | |
| Return on equityHigher is better · 1,252 reported | Not reported | 3.2% | — | — | Context only |
| Gross marginHigher is better · 1,394 reported | 81.6% | 45.9% | 89% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 5 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 1,183 | 117M USD | 11 | 40 | |
| 1,183 | 9M USD | 11 | 45 | |
| 1,183 | 2.2B USD | 11 | 48 | |
| 1,183 | 284M AUD (≈$188M) | 11 | 36 | |
| 1,183 | 474M USD | 11 | 25 | |
| 1,183 | 1.2B USD | 11 | 40 | |
| 1,183 | 976M USD | 11 | 36 | |
| 1,196 | 7.2B TWD (≈$224M) | 10 | 41 | |
| 1,196 | 3.9B USD | 10 | 47 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score